Highlights and Quick Summary
- Shareholders Equity (Tangible) for the quarter ending March 31, 2022 was $11.6 Million (a -38.44% decrease compared to previous quarter)
- Year-over-year quarterly Shareholders Equity (Tangible) decreased by -5.31%
- Annual Shareholders Equity (Tangible) for 2021 was $18.9 Million (a -16.4% decrease from previous year)
- Annual Shareholders Equity (Tangible) for 2020 was $22.6 Million (a 31.23% increase from previous year)
- Annual Shareholders Equity (Tangible) for 2019 was $17.2 Million (a -65.23% decrease from previous year)
Visit stockrow.com/ALNA
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shareholders Equity (Tangible) of Allena Pharmaceuticals, Inc.
Most recent Shareholders Equity (Tangible)of ALNA including historical data for past 10 years.Interactive Chart of Shareholders Equity (Tangible) of Allena Pharmaceuticals, Inc.
Allena Pharmaceuticals, Inc. Shareholders Equity (Tangible) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $11.62 | – | – | – | – |
2021 | $18.87 | $26.03 | $12.27 | $23.5 | $18.87 |
2020 | $22.57 | $18.18 | $18.37 | $10.66 | $22.57 |
2019 | $17.2 | $25.19 | $37.67 | $38.68 | $17.2 |
2018 | $49.46 | $58.45 | $67.35 | $75.41 | $49.46 |
2017 | – | – | $82.87 | $21.78 | $82.87 |
2016 | – | – | – | – | $36.45 |
2015 | $60.69 | – | – | – | $60.69 |
Business Profile of Allena Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.